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The aim was to report an unusual case of insulinoma presenting with long-standing depression and primary testicular failure. We
describe a 34-year-old male with clinical, laboratory, and radiologic data consistent with islet cell tumor and seminiferous tubule
failure primary hypogonadism. The literature is reviewed relative to the component of this syndrome, and a possible association
is discussed. The subject was investigated for a long-standing history of depression requiring medical attention because of mental
confusion and slurred speech and was found to have an insulinoma. He was diagnosed with primary gonadal failure and physical
examination showed no evidence of dysmorphic features. Chromosomal analysis revealed normal 46 XY and testicular biopsy
showed Sertoli cell only syndrome (SCOS). Biochemistry revealed endogenous hyperinsulinism and histology confirmed an islet
cell tumor. He remained euglycemic postoperatively and on followup. From this report, we emphasize drawing clinicians’ attention
to the possibility of an association between insulinoma and primary testicular failure and suggest consideration of this diagnosis
in patients with hypergonadotropic hypogonadism who may present with infertility.
1. Introduction
Primary infertility and insulinoma have not been elucidated
previously. Here, we report a patient with a history of long-
standing symptoms of depression and hypogonadism and
neuroglycopenic symptoms of recurrent episodic hypogly-
cemia. At presentation he complained of slurred speech, dou-
ble vision, and feeling of blackout. Further assessment also
revealed reduced libido and erectile dysfunction. Laboratory
evaluation showed elevated serum FSH, azoospermia, and
fasting hyperinsulinism confirmed to be an islet cell tumor.
Hypoglycemic symptoms resolved following partial pancrea-
tectomy.
2. Case Report
A 34-year-old male was referred for further assessment of
insulinoma in 2011. Prior to that he had several years of
depression including suicidal thoughts and had been seeing
a clinical psychologist. His symptoms were that of episodic
slurred speech, double vision, and blackout. The symptoms
were worsened by exertion as evidenced by several home
blood glucose readings of ≤2mmol/L. He was never sexually
active and did not smoke, drink alcohol, or use any recre-
ational drugs or hypoglycemic medications. There was no
family history of diabetes or hypoglycemia. Clinical exami-
nation revealed body weight to be 65 kg, height 174.6 cm, and
bodymass index 21.4 kg/m2. No evidence of disproportionate
body segmentswas found.He had normal body andmale pat-
tern pubic hair and no gynecomastia. Both testes were of
small volume measuring 8mL and normal consistency. His
sense of smell was unremarkable. Neck examination showed
no evidence of neck mass or goiter and was clinically
euthyroid.
The 72-hr fasting test was terminated prematurely owing
to symptoms of hypoglycemia. The laboratory investigation
was in keeping with endogenous hyperinsulinism. Notably,
the serum glucose levels were low variously ranging between
38 and 55mg/dL (normal range 70–110), with inappropriately
normal serum insulin and C-peptide of 8–12mU/L (fasting
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Table 1: Serum hormone concentrations and semen parameters in
patient with insulinoma.
Ref range Result
Test
Follicle stimulating hormone
(mIU/L) <10 28
Luteinizing hormone (mIU/L) <9 8
Testosterone (ng/dL) 300–1200 291
Free testosterone (ng/dL) 9–30 5.3
Sex hormone binding globulin
(nmo/L) 10.0–70.0 38
Estradiol (pg/mL) 10–40 25
Prolactin (mIU/L) <500 543
Seminal fluid analysis
Age at testing (hr⋅min) <2.01 1.05
Semen volume (mL) >1.4 2
Viscosity — ↑↑
Sperm concentration >14 0
Leucocytes <1 <1
normal range 5–20) and 0.6—1.0 nmol/L (fasting normal
range 0.5–1.0), respectively. Serum proinsulin was markedly
elevated at 68.4 pmol/L (normal <13.3) and as expected beta-
hydroxybutyrate concentration was consistently suppressed
0.10mmol/L (<0.30). Serum and urine sulphonylurea screens
were negative. Intraoperative pancreatic ultrasound revealed
7 × 11mm adenoma localized on the head of the pancreas;
however PET gallium octreotide scan was unable to detect
any focal somatostatin receptor avid lesion. Histology of the
surgical excision confirmed islet cell tumor. His other bio-
chemistry was in keeping with primary testicular failure with
elevated FSH and normal LH and low-normal serum testos-
terone (Table 1). Semen analysis revealed azoospermia. Kary-
otype showed 46XY and no evidence ofmicrodeletion on the
Y chromosome. Testicular biopsy was consistent with Sertoli
cell only syndrome (SCOS) with an occasional hyalinised
tubule (Figure 1).
3. Discussion
We report the first case of insulinoma presenting with hyper-
gonadotropic hypogonadism. The etiology of the nonob-
structive azoospermia associated hypogonadism in our sub-
ject was investigated including chromosomal analysis which
showed a normal male 46XY pattern and testicular biopsy
confirmed Sertoli cell only syndrome in line with the elevated
serum FSH, normal or high LH, normal or low testosterone,
and low inhibin B [1]. In determining the etiology of the
SCOS there was no history of usage of any toxins, radiation
exposure, and viral orchitis or Y microdeletion. We opined
that the shrunken testes at presentation might suggest occur-
rence of testicular disease’s at peri- or post pubertal stage in
line with Jahnukainen et al. observation [2].
The association between the primary hypogonadism and
insulinoma in our subject is not clear. Although coincidental
Figure 1: Histology of testicular biopsy of the patient showing
seminiferous tubules containing Sertoli cells only (arrowed) with
surrounding thickened tunica propria consistent with Sertoli cell
only syndrome. Haematoxylin and eosin stain, magnification ×40.
finding is possible in that cause and effect had not been
proven, we believe testicular injury from recurrent possibly
long standing hypoglycemic attacks could be responsible.
This phenomenon has not been reported in humans yet
though testicular feminization was described in one case of
insulinoma [3]. In support of our hypothesis, studies on
animal model have confirmed testicular infarction caused by
acute hypoglycemia [4, 5], but as of yet no link was reported
with SCOS. Interestingly Van Demark and colleagues
reported seminiferous tubular cell degeneration in adult but
not in prepubertal rodents exposed to hypoglycemic coma
[6]. The histologic pattern of SCOS in this report was con-
sistent with germinal cell aplasia described in animal models
observed in experimental studies involving severe hypogly-
cemia. SCOSwas reported in humans to be caused by hypoxia
[7], yet as far as we know there has been no link with hypo-
glycemia.With the reported high prevalence of testicular can-
cer in SCOS, our subject who had an islet cell tumour treated
would need close surveillance for potential germinal cell tum-
ors [8].
The implication of this report for diabetic subjects with
recurrent hypoglycemia is obvious. It has long being estab-
lished that testicular dysfunction, impotence, and decreased
fertility are more common in type 1 diabetes mellitus (DM1)
patients who are at higher risk of hypoglycemia compared to
those with type 2 diabetes [9]. Furthermore poor semen qual-
ity has also been reported in DM1 men, including decreased
sperm motility and concentration, abnormal morphology,
and increased seminal plasma abnormalities [10, 11]. In addi-
tion, diabetic men may have decreased serum testosterone
due to impaired Leydig cell function in line with SCOS [12].
The reason for this was not conclusively investigated.Mallidis
et al. reported autoimmunity to be the likely etiopathogenesis
of gonadal dysfunction in DM1 [9]. Thus the insulinoma-
primary hypogonadism syndrome needs to be identified so as
not to misdiagnose autoimmune polyglandular failure with a
combination of Addison’s disease which may present with
hypoglycemia and autoimmune testicular failure [13]. Our
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index case had no clinical and/or biochemical evidence of
autoimmune related diseases.
4. Conclusion
We report a case of insulinoma presenting with neurogly-
copenic symptoms, primary testicular failure, and Sertoli cell
only syndrome.The likely link had been discussed. Consider-
ing that this is a single case report, further prospective study
on a larger population at risk of recurrent hypoglycemia and
infertility is needed to confirm our findings.
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